Successful treatment of a patient with HIV-associated multicentric castleman disease (MCD) with thalidomide

被引：33

作者：

Jung, CP

Emmerich, B

Goebel, FD

Bogner, JR

机构：

[1] Univ Munich, Klinikum Innenstadt, Med Poliklin, Dept Hematol & Oncol, Munich, Germany

[2] Univ Munich, Klinikum Innenstadt, Med Klin, Dept Hematol & Oncol, Munich, Germany

[3] Univ Munich, Klinikum Innenstadt, Med Poliklin, Dept Infectiology, Munich, Germany

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2004年 / 75卷 / 03期

关键词：

D O I：

10.1002/ajh.10467

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：176 / 177

页数：2

共 5 条

[1] Kaposi sarcoma-associated herpesvirus infects monotypic (IgMλ) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders [J].

Du, MQ ;

Liu, HX ;

Diss, TC ;

Ye, HT ;

Hamoudi, RA ;

Dupin, N ;

Meignin, V ;

Oksenhendler, E ;

Boshoff, C ;

Isaacson, PG .

BLOOD, 2001, 97 (07) :2130-2136

[2] Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide [J].

Lee, FC ;

Merchant, SH .

AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (01) :48-53

[3] High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease [J].

Oksenhendler, E ;

Boulanger, E ;

Galicier, L ;

Du, MQ ;

Dupin, N ;

Diss, TC ;

Hamoudi, R ;

Daniel, MT ;

Agbalika, F ;

Boshoff, C ;

Clauvel, JP ;

Isaacson, PG ;

Meignin, V .

BLOOD, 2002, 99 (07) :2331-2336

[4] Antitumor activity of thalidomide in refractory multiple myeloma. [J].

Singhal, S ;

Mehta, J ;

Desikan, R ;

Ayers, D ;

Roberson, P ;

Eddlemon, P ;

Munshi, N ;

Anaissie, E ;

Wilson, C ;

Dhodapkar, M ;

Zeldis, J ;

Barlogie, B ;

Siegel, D ;

Crowley, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1565-1571

[5]

YOSHIZAKI K, 1989, BLOOD, V74, P1360

← 1 →